Hypertonic saline and mannitol therapy in critical care neurology

Journal of Intensive Care Medicine

Volumn 28, Issue 1, 2013, Pages 3-11

  Hinson, Holly E ^a   Stein, Deborah ^b   Sheth, Kevin N ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral edema; Hypertonic saline; Mannitol; Osmotic therapy

Indexed keywords

DEXTRAN; LACTATE SODIUM; MANNITOL; OSMOTIC AGENT; PLACEBO; RINGER LACTATE SOLUTION; SODIUM; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; BLOOD BRAIN BARRIER; BLOOD OSMOLARITY; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN HERNIA; BRAIN ISCHEMIA; CONTINUOUS INFUSION; DIURESIS; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HYPERNATREMIA; HYPOKALEMIA; HYPOVOLEMIA; INTENSIVE CARE; INTRACRANIAL PRESSURE; KIDNEY FAILURE; KIDNEY TUBULE; LIVER FAILURE; LOW DRUG DOSE; METABOLIC ACIDOSIS; NEUROLOGY; NONHUMAN; PRIORITY JOURNAL; REBOUND; REVIEW; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

CRITICAL CARE; FLUID THERAPY; HUMANS; MANNITOL; NERVOUS SYSTEM DISEASES; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 84875876545     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066611400688     Document Type: Review

References (76)

1. Javid M, Settlage P. Effect of urea on cerebrospinal fluid pressure in human subjects; preliminary report. J Am Med Assoc. 17 1956;160(11): 943-949.
2. Cantore G, Guidetti B, Virno M. Oral glycerol for the reduction of intracranial pressure. J Neurosurg. 1964;21: 278-283.
3. Hemmer R. Comparative studies on the drug-induced decrease in cerebral pressure. Med Klin. 20, 1961;56: 105-108.
4. Wise BL, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. J Neurosurg. 1962;19: 1038-1043.
5. Burke AM, Quest DO, Chien S, Cerri C. The effects of mannitol on blood viscosity. J Neurosurg. 1981;55(4): 550-553.
6. Willerson JT, Watson JT, Hutton I, Fixler DE, Curry GC, Templeton GH. The influence of hypertonic mannitol on regional myocardial blood flow during acute and chronic myocardial ischemia in anesthetized and awake intact dogs. J Clin Invest. 1975;55(5): 892-902.
7. Muizelaar JP, Lutz HA 3rd, Becker DP. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg. 1984;61(4): 700-706.
8. Wisner DH, Schuster L, Quinn C. Hypertonic saline resuscitation of head injury: effects on cerebral water content. J Trauma. Jan 1990;30(1): 75-78.
9. Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology. Feb 1999;52(3): 583-587.
10. Paczynski RP, He YY, Diringer MN, Hsu CY. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke. 1997;28(7): 1437-1443; discussion 1444.
11. Videen TO, Zazulia AR, Manno EM, et al. Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology. 11 2001;57(11): 2120-2122.
12. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma. 2007;24(Suppl 1):S14-S20.
13. Oken DE. Renal and extrarenal considerations in high-dose mannitol therapy. Ren Fail. 1994;16(1): 147-159.
14. Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg. 1993;128(9): 1003-1011; ; discussion 1011-1003.
15. Wade CE, Grady JJ, Kramer GC, Younes RN, Gehlsen K, Holcroft JW. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma. 1997;42(suppl 5):S61-S65.
16. Anderson JT, Wisner DH, Sullivan PE, et al. Initial small-volume hypertonic resuscitation of shock and brain injury: short- and long-term effects. J Trauma. 1997;42(4): 592-600; ; discussion 600-591.
17. Bacher A, Wei J, Grafe MR, Quast MJ, Zornow MH. Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline. Crit Care Med. 1998;26(1): 108-114.
18. Prough DS, Whitley JM, Taylor CL, Deal DD, DeWitt DS. Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline. Influence of a subdural mass. Anesthesiology. 1991;75(2): 319-327.
19. Schmoker JD, Zhuang J, Shackford SR. Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock. J Trauma. 1991; 31(12): 1607-1613.
20. Ziai WC, Toung TJ, Bhardwaj A. Hypertonic saline: first-line therapy for cerebral edema? J Neurol Sci. 15 2007;261(1-2): 157-166.
21. Froelich M, Ni Q, Wess C, Ougorets I, Hartl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4): 1433-1441.
22. Qureshi AI, Suarez JI, Castro A, Bhardwaj A. Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. J Trauma. 1999; 47(4): 659-665.
23. Ichai C, Armando G, Orban JC, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35(3): 471-479.
24. Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36(3): 795-800.
25. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. Jan 2005;33(1): 196-202; discussion 257-198.
26. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]. Crit Care. Oct 5 2005;9(5):R530-540.
27. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003;31(6): 1683-1687.
28. Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009; 67(2): 277-282.
29. James HE. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien). 1980;51(3-4): 161-172.
30. BeckerDP. The alleviation of increased intracranial pressure by the chronic adminitration of osmotic agents. Berlin: Springer; 1972.
31. Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg. 1985; 63(1): 43-48.
32. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26(3): 440-446.
33. Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res. 1999;21(8): 758-764.
34. Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma. 2000;17(1): 41-51.
35. Schatzmann C, Heissler HE, Konig K, et al. Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl. 1998;71: 31-33.
36. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102(6): 1836-1846.
37. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4): 727-736; ; discussion 727-736.
38. Oddo M, Levine JM, Frangos S, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry. 2009;80(8): 916-920.
39. Baker AJ, Rhind SG, Morrison LJ, et al. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. J Neurotrauma. 2009;26(8): 1227-1240.
40. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(suppl 1):S1-S106.
41. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema bymultiple-dose mannitol. JNeurosurg. 1992;77(4): 584-589.
42. BereczkiD,Mihalka L, Szatmari S, et al.Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke. 2003;34(7): 1730-1735.
43. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29(8): 1550-1555.
44. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1): 136-140.
45. Bhardwaj A, Harukuni I, Murphy SJ, et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000;31(7): 1694-1701.
46. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5): 1655-1711.
47. BermuellerC,Thal SC, Plesnila N,Schmid-ElsaesserR,Kreimeier U, Zausinger S. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol. J Neurol Sci. Feb 15 2006;241(1-2): 73-82.
48. Zausinger S, Thal SC, Kreimeier U, Messmer K, Schmid- Elsaesser R. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats. Neurosurgery. 2004;55(3): 679-686; discussion 686-677.
49. Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 2006;34(12): 2912-2917.
50. Tseng MY, Al-Rawi PG, Czosnyka M, et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg. 2007;107(2): 274-282.
51. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 15 2005;234(1-2): 41-45.
52. Kalita J, Misra UK, Ranjan P, Pradhan PK, Das BK. Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. J Neurol Sci. 15, 2004;224(1-2): 19-22.
53. Qureshi AI, Wilson DA, Traystman RJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neurosurg Anesthesiol. 2002;14(1): 22-30.
54. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison betweenmannitol and hypertonic saline. Neurosurgery. 1999;44(5): 1055-1063; ; discussion 1063-1054.
55. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int. 2005;47(1-2): 78-83.
56. Blei AT. The pathophysiology of brain edema in acute liver failure. Neurochem Int. 2005;47(1-2): 71-77.
57. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23(7): 625-629.
58. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39(2): 464-470.
59. Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000; 28(5): 1556-1564.
60. Koenig MA, Bryan M, Lewin JL, 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 25 2008;70(13): 1023-1029.
61. Rosner MH, Ronco C. Dysnatremias in the intensive care unit. Contrib Nephrol. 2010;165: 292-298.
62. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004;1(2): 219-233.
63. Becker D, Vries J. The Alleviation of Increased Intracranial Pressure by the Chronic Administration of Osmotic Agents. New York: Springer; 1972.
64. Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care. 2006; 21(2): 163-172.
65. Cloyd JC, Snyder BD, Cleeremans B, Bundlie SR, Blomquist CH, Lakatua DJ. Mannitol pharmacokinetics and serum osmolality in dogs and humans. J Pharmacol Exp Ther. 1986;236(2): 301-306.
66. Garcia-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med. 2004;32(4): 986-991.
67. Rabetoy GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much? Ann Pharmacother. 1993;27(1): 25-28.
68. Temes SP, Lilien OM, Chamberlain W. A direct vasoconstrictor effect of mannitol on the renal artery. Surg Gynecol Obstet. 1975;141(2): 223-226.
69. Whelan TV, Bacon ME, Madden M, Patel TG, Handy R. Acute renal failure associated with mannitol intoxication. Report of a case. Arch Intern Med. 1984;144(10): 2053-2055.
70. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitolinduced acute renal failure. Medicine (Baltimore). 1990;69(3): 153-159.
71. Huang PP, Stucky FS, Dimick AR, Treat RC, Bessey PQ, Rue LW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg. 1995;221(5): 543-554; ; discussion 554-547.
72. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med. 2000;28(4): 1144-1151.
73. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med. 2000;28(4): 1136-1143.
74. Kraus MA. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances. Semin Dial. Mar-2009;22(2): 137-140.
75. Nau R. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet. 2000;38(1): 23-40.
76. Forsyth LL, Liu-DeRyke X, Parker D Jr, Rhoney DH. Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy. 2008; 28(4): 469-484.